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Abstract
 
The dominant lymphocytes in human and murine implantation sites are transient, pregnancy-
associated uterine natural killer (uNK) cells. These cells are a major source of interferon (IFN)-
 
g
 
.
Implantation sites in mice lacking uNK cells (alymphoid recombinase activating gene [RAG]-
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 common cytokine receptor chain 
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]
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) or IFN-
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 signaling (IFN-
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or IFN-
 
g
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2
 
/
 
2
 
) fail to initiate normal pregnancy-induced modification of decidual arteries and display
hypocellularity or necrosis of decidua. To investigate the functions of uNK cell–derived IFN-
 
g
 
during pregnancy, RAG-2
 
2
 
/
 
2
 
g
 
c
 
2
 
/
 
2
 
 females were engrafted with bone marrow from IFN-
 
g
 
2
 
/
 
2
 
mice, IFN-
 
g
 
 signal-disrupted mice (IFN-
 
g
 
R
 
a
 
2
 
/
 
2 
 
or signal transducer and activator of tran-
scription [Stat]-1
 
2
 
/
 
2
 
), or from mice able to establish normal uNK cells (severe combined im-
munodeficient [SCID] or C57BL/6). Mated recipients were analyzed at midgestation. All
grafts established uNK cells. Grafts from IFN-
 
g
 
2
 
/
 
2
 
 mice did not reverse host vascular or decid-
ual pathology. Grafts from all other donors promoted modification of decidual arteries and de-
cidual cellularity. Grafts from IFN-
 
g
 
R
 
a
 
2
 
/
 
2
 
 or Stat-1
 
2
 
/
 
2
 
 mice overproduced uNK cells, all of
which were immature. Grafts from IFN-
 
g
 
2
 
/
 
2
 
, SCID, or C57BL/6 mice produced normal,
mature uNK cells. Administration of murine recombinant IFN-
 
g
 
 to pregnant RAG-2
 
2
 
/
 
2
 
g
 
c
 
2
 
/
 
2
 
mice initiated decidual vessel modification and promoted decidual cellularity in the absence of
uNK cells. These in vivo findings strongly suggest that uNK cell–derived IFN-
 
g 
 
modifies the
expression of genes in the uterine vasculature and stroma, which initiates vessel instability and
facilitates pregnancy-induced remodeling of decidual arteries.
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marrow transplantation • tumor necrosis factor 
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Introduction
 
IFN-
 
g
 
, a cytokine secreted predominantly by activated NK
cells and T cells, has important regulatory effects on many
cell types (1, 2). During early pregnancy in humans and ro-
dents, an NK cell subset, known as uterine (u)NK
 
1
 
 cells, is
the most abundant maternal lymphocyte population in the
uterus (3, 4). IFN-
 
g
 
 mRNA has been documented in
healthy human and murine implantation sites (5, 6). uNK
cells are among the cells expressing IFN-
 
g
 
 mRNA and are
positive for IFN-
 
g
 
 protein (7, 8). In normal mice and T
and B cell–deficient SCID mice, concentrations of IFN-
 
g
 
have been measured in the mesometrial triangle where
uNK cells aggregate. Local IFN-
 
g
 
 concentrations increased
from baseline values found in nonpregnant uteri to peak
amounts of 
 
z
 
10 U per implantation site on gestation day
(gd) 10 (9). In tg
 
e
 
26 females (uNK
 
2
 
NK
 
2
 
T
 
2
 
), pregnancy
induced a 10-fold lower elevation in mesometrial IFN-
 
g
 
,
suggesting that uNK cells are the major source of IFN-
 
g
 
 in
the pregnant mouse uterus. At midgestation, histologic
anomalies are found within implantation sites of mice ge-
netically ablated in IFN-
 
g
 
 or IFN-
 
g
 
R
 
a
 
. Three striking
features are consistent. First, there are excessive numbers of
uNK cells, which are uncharacteristically small and have
limited numbers of cytoplasmic granules (9). Second, the
major decidual arteries, analogous to the uterine spiral ar-
teries of women, do not undergo normal gestation-induced
remodeling. Third, decidualization is initiated, but cellular-
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ity of the decidua is not maintained. In contrast to the hy-
pocellularity of decidua in uNK cell–deficient mice, de-
cidua in IFN-
 
g
 
2
 
/
 
2
 
 and IFN-
 
g
 
R
 
a
 
2
 
/
 
2
 
 mice progress to
overt necrosis during the second half of gestation. These
findings led us to hypothesize that uNK cell–derived IFN-
 
g
 
contributes to initiation of pregnancy-induced uterine vas-
cular modification, maintenance of decidual integrity, and
regulation of maturation and senescence of the uNK cell
population.
During pregnancy, distinctive changes occur in uterine
tissues including endometrial stromal cells, leukocytes, and
blood vessels (BV). In primates and rodents with hemocho-
rial placentae, decidualization of the uterus is hormonally
regulated (10, 11). Decidualization is triggered late in each
menstrual cycle in women and by implantation in mice
(10, 12). During decidualization, activation of small agran-
ular lymphocytes, believed to be precursors of uNK cells, is
thought to occur and lead to the appearance of granulated
uNK cells that rapidly proliferate within the uterus. In
mice, mature uNK cells become localized to the mesome-
trial side of each implantation site. Some are found within
arterial vessels and tissue of the decidua basalis, but more
form a lymphocyte-rich structure known as either the me-
sometrial lymphoid aggregate of pregnancy (MLAp) or the
metrial gland (13). uNK cells reach peak numbers and
IFN-
 
g
 
 production at about the middle of the 19-d mouse
gestation (9). Beginning at gd 12, uNK cells undergo pro-
gressive nuclear fragmentation and decline in number (14).
In mice, the major decidual arteries undergo gestationally
induced modification beginning about gd 9 (15). This pro-
cess involves thinning of the muscular coat, increasing lu-
men diameter, and vessel elongation (16).
tg
 
e
 
26 females transplanted with bone marrow (BM)
from SCID mice have high numbers of uNK cells, decidual
vessel modification, and normal decidual cellularity during
pregnancy (17). This suggests that the highly specific local-
Figure 1. Photomicrographs of
uNK cells in MLAp cross-sections
from BM-reconstituted RAG-22/2
gc
2/2 mice (B–F) and nonmanipulated
RAG-22/2gc
2/2 mice (A) at gd 12.
Excessive numbers of uNK cells (ar-
rows) with immature appearance and
poor granule development were
present in MLAp of RAG-22/2gc
2/2
mice receiving BM from IFN-gRa2/2
or Stat-12/2 mice (E and F) compared
with those receiving control B6 BM
(B). e1, representative hypogranular
uNK cells from E and F at higher mag-
nification. Normal frequencies of ma-
ture uNK cells were observed in
MLAp of RAG-22/2gc
2/2 mice en-
grafted with BM from IFN-g2/2 or
SCID mice (C and D). b1, representa-
tive uNK cells with normal granularity
from B–D at higher magnification. No
uNK cells were present in nonmanipu-
lated RAG-22/2gc
2/2 mice (A). A–F
were stained with PAS. Bars, 50 mm. 
261
 
Ashkar et al.
 
ization of uNK cells may provide short range cytokine sig-
naling that could influence gene expression in target tissues
including BV walls, endothelium, and the uterine stroma
(18). IFN-
 
g
 
 regulates the expression of 
 
.
 
0.5% of the
mouse genome, including genes involved in smooth mus-
cle cell proliferation, cell adhesion, regulation of MHC
gene expression, apoptosis, and processing pathways for
protein synthesis and packaging (2, 19). Specific examples
of IFN-
 
g
 
–regulated genes that could be important in im-
plantation sites include inducible nitric oxide synthase
(iNOS), endothelial (e)NOS, and endothelin-1, all major
regulators of vascular contractility (2), and 
 
a
 
2
 
-macroglobu-
lin, a regulator of proteases and cytokines that is the major
known product of mesometrial decidua (reference 20 and
our unpublished data).
The studies presented here were undertaken to assess the
role of IFN-
 
g
 
 derived from uNK cells in decidual vascular
remodeling, maintenance of decidual integrity, and matura-
tion of uNK cells in vivo. In this work, recombinase activat-
ing gene (RAG)-2
 
2
 
/
 
2
 
 common cytokine receptor chain 
 
g
 
(
 
g
 
c
 
)
 
2
 
/
 
2
 
 mice were used as transplant recipients. Due to com-
bined deficiencies of products from RAG-2 and 
 
g
 
c
 
, these fe-
males lack all lymphocyte subsets but are reliable breeders.
RAG-2
 
2
 
/
 
2
 
g
 
c
2/2 are superior to tge26 females for these
studies because they have an absolute deficiency in uNK
cells rather than the greatly reduced frequency observed in
tge26 mice (1% of normal; reference 21). Histologically, the
anomalies of the decidual vessels and decidua are identical in
both strains, and pregnancy in RAG-22/2gc
2/2 mice in-
duces mesometrial IFN-g at the same low concentrations as
in tge26 mice (9, 15, 21). Different patterns of morphologi-
cal changes were documented, without pregnancy loss, in
the decidual arteries, decidua, and MLAp of syngeneically
mated RAG-22/2gc
2/2 females that received BM from cy-
tokine or cytokine signal gene–disrupted donors or repeated
injections of murine recombinant (mr)IFN-g. This shows
that IFN-g plays an important role in healthy implantation
sites and that the RAG-22/2gc
2/2 mouse is a new and in-
formative model with which to address the biological signif-
icance of IFN-g in the pregnant mammalian uterus.
Materials and Methods
Mice. IFN-g2/2, IFN-gRa2/2, TNF-a2/2, TNF-R12/2,
and C57BL/6J (B6) mice were obtained from The Jackson Labo-
ratory. Signal transducer and activator of transcription (Stat)-12/2
mice and breeding pairs of C.B-17 scid/scid (SCID) mice were
purchased from Taconic Farms Inc. B6 congenic RAG-22/2gc
2/2
mice (22) were bred under barrier husbandry at the University of
Guelph (OMAFRA Isolation Unit). Female RAG-22/2gc
2/2,
Stat-12/2, or B6 mice were mated by overnight cohabitation
with syngeneic males. The morning a vaginal plug was observed
was considered gd 0. At gd 12, pregnant mice were killed by
CO2 inhalation, which was followed by cervical dislocation.
Pregnant uteri were dissected and viable implantation sites were
enumerated and then processed for study. No significant fetal loss
was observed after any of the matings.
Tissue Acquisition and ELISA Quantification of IFN-g. To
quantify mesometrial concentrations of IFN-g, mesometrial tis-
sues were dissected from nonpregnant RAG-22/2gc
2/2 mice or
from implantation sites on gd 6–8, 10–13, or 16. Dissected tissue
was immediately homogenized, and supernatants were collected
and assayed for IFN-g using a standard ELISA as described previ-
ously (9).
BM Transplantation. 6–8-wk-old RAG-22/2gc
2/2 females
were used as recipients of BM. Each recipient was pretreated with
a single i.p. injection of 150 mg/kg of 5-fluorouracil (5-FU) 48 h
before BM infusion (23). 6–8-wk-old IFN-g2/2, IFN-gRa2/2,
Stat-12/2, SCID, B6, TNF-a2/2, or TNF-R12/2 mice were
used as BM donors. Donor cells were depleted of RBCs using
hypotonic lysis. When donor cells were histoincompatible, pre-
treatment with anti–Thy-1.2 and complement was also used as
Figure 2. Density of uNK cells
in MLAp and cross-sectional area
morphometry of the MLAp in
engrafted RAG-22/2gc
2/2 mice
and control B6 mice at gd 12.
The left y-axis indicates number
of uNK cells per square millime-
ter in MLAp, and the right y-axis
indicates MLAp cross-sectional
area. RAG-22/2gc
2/2 recipients
of IFN-gRa2/2 or Stat-12/2
BM cells had larger MLAp areas
and higher uNK cell density than
B6 BM–engrafted controls (*P ,
0.01). No significant differences
were found in uNK cell density
and area of MLAp between
RAG-22/2gc
2/2 recipients of
IFN-g2/2 BM or SCID BM and
B6 BM–engrafted controls. Values
were obtained from 11 central
cross-sections per implantation
site, two to three implantation
sites per dam. Four to five dams
were used in each experimental
group.262 Uterine Effects of IFN-g during Normal Pregnancy
previously described (23, 17). A total of 2 3 107 viable BM cells
was given i.v. to each 5-FU–treated RAG-22/2gc
2/2 female. 3
wk later, recipients were paired with RAG-22/2gc
2/2 males for
mating and killed at gd 12.
Assay of mrIFN-g and Treatment of Mice with mrIFN-g. Ho-
mozygously mated RAG-22/2gc
2/2 mice were treated once per
day for 6 d with mrIFN-g (Sigma-Aldrich) or placebo (PBS) i.v.
or i.p., beginning on gd 6, and killed at gd 12. Doses were 0 (n 5
4), 100 (n 5 2), 300 (n 5 2), or 1,000 U (n 5 5) in 0.2 ml of
PBS. Viability of implantation sites was recorded, and viable im-
plants were processed for study. Bioactivity of IFN-g was con-
firmed in two assays: WEHI 279 cell proliferation inhibition (24)
and viral inhibition using L-929 cells infected with encepho-
lomyocarditis virus (25).
Histological Analysis. Implantation sites were fixed in Bouin’s
fixative (Fisher Scientific) and processed into paraffin using stan-
dard methodology. Two or three implantation sites from each
pregnant mouse (four to five pregnant females per study group
except in the mrIFN-g treatment study) were serially sectioned
(7 mm) and stained with hematoxylin and eosin or periodic acid-
Schiff (PAS) before microscopic examination. The number of
uNK cells per square millimeter was measured on 11 sections
from the center of each implantation site and averaged as previ-
ously described (9). Cross-sectional areas of the MLAp and ratios
for vessel/lumen diameters of the main decidual arteries, cut in
cross-section, were measured on the same slides that were used
for uNK cell numeration using OPTIMAS™ image analysis soft-
ware (version 6.2; Optimas Corp.). The means of experimental
groups were compared using two-factor ANOVA (analysis of
variance). The variances between mice and implantation sites
were considered as analytic factors (P , 0.05). Groups with sig-
nificantly different means were identified using Tukey’s test (P ,
0.05).
Results
Mesometrial Concentrations of IFN-g in RAG-22/2gc
2/2
Mice. Supernatants from homogenates of mesometrial tis-
sues from cycling RAG-22/2gc
2/2 mice contained very
low concentrations of IFN-g (,0.1 U per uterus; data not
shown). This is consistent with previously reported results
Figure 3. Comparison of decidual
artery remodeling at implantation
sites from nonmanipulated and BM-
engrafted RAG-22/2gc
2/2 mice on
gd 12. A is a typical cross-section of
unmodified artery from an unmanipu-
lated RAG-22/2gc
2/2 mouse. C is a
typical cross-section of an unmodified
decidual artery in a RAG-22/2gc
2/2
mouse engrafted with IFN-g2/2 BM.
B–F show normal, pregnancy-induced
remodeling of the spiral artery in
RAG-22/2gc
2/2 mice infused with
BM from B6, SCID, IFN-gRa2/2,
or Stat-12/2 mice, respectively. Ar-
rows point to vessel-associated uNK
cells. A–F were stained with PAS.
Bars, 50 mm.263 Ashkar et al.
in cycling normal and immune-deficient mice (9). During
pregnancy (gd 6–8, 10–13, and 16), the concentration of
IFN-g was stable at 1 U per implantation site. This is simi-
lar to results previously reported in T2NK2uNK2B1 tge26
mice and is different from the results in uNK1 mice. The
measured values were above background (data not shown),
since the assay did not detect IFN-g in mesometrial uterine
homogenates from IFN-g2/2 females (9).
Assessment of Implantation Sites in RAG-22/2gc
2/2 Females
Engrafted with Normal or IFN-g Signal-disrupted BM Cells.
Pregnancy in NK cell–deficient RAG-22/2gc
2/2 mice is
associated with an absolute absence of uNK cells, absence
of MLAp, hypocellularity of decidua, and unmodified de-
cidual arteries, despite the low amounts of IFN-g from
nonlymphoid sources. To investigate the actions of IFN-g
derived from uNK cells, implantation sites were studied
from RAG-22/2gc
2/2 females engrafted with BM cells un-
able to produce IFN-g but able to respond to host IFN-g
(BM from IFN-g2/2 mice). These females were compared
with RAG-22/2gc
2/2 females engrafted with BM cells able
to produce IFN-g (from B6 or SCID mice). To establish
values for normal density and granularity of uNK cells and
their effects on decidua and decidual arteries, in an en-
grafted RAG-22/2gc
2/2 female, implantation sites from
RAG-22/2gc
2/2 recipients of B6 BM were compared with
implantation sites from gd-matched unmanipulated con-
genic B6 mice. In comparison with unmanipulated B6
controls, transplantation of 2 3 107 BM cells from B6 to
RAG-22/2gc
2/2 females established similar numbers of
uNK cells with morphology typical for the gd 12, estab-
lished similar cross-sectional areas of MLAp, induced com-
parable vessel/lumen ratios in the spiral arteries, and
induced decidual cellularity that was indistinguishable mor-
phologically. The values from the B6 transplanted RAG-
22/2gc
2/2 mice were therefore used as the control for all
other BM transplant experiments. Engraftment of RAG-
22/2gc
2/2 females with BM from IFN-g2/2 mice restored
normal numbers of uNK cells with morphology typical for
gd 12 and induced an MLAp of normal size (Figs. 1 and 2).
However, IFN-g–deficient uNK cells failed to initiate
pregnancy-induced remodeling of spiral arteries (Fig. 3).
The decidual arterial vessel/lumen ratios in IFN-g2/2
BM–engrafted mice were significantly different from the
controls but similar to those in nonengrafted RAG-22/2
gc
2/2 mice (Fig. 4). Decidua in these mice were either ne-
crotic (Fig. 5) or hypocellular compared with B6 BM–
engrafted controls. These results highlight an essential role
for uNK-derived IFN-g in arterial remodeling during
pregnancy.
Consistent with previous observations in tge26 mice
(17), RAG-22/2gc
2/2 females receiving BM from SCID
mice demonstrated normal density of morphologically typ-
ical uNK cells, cross-sectional areas of MLAp, remodeling
of decidual arteries, and decidual cellularity similar to that
in B6 BM–engrafted controls (Figs. 1–5). This experiment
identifies NK cells rather than T cells as the important cell
type providing IFN-g within implantation sites.
Absence of IFN-g signaling pathways is associated with
excessive numbers of small, hypogranular uNK cells, huge
MLAp, unmodified arteries, and necrosis in decidua during
pregnancy (reference 9 and our unpublished data). To in-
vestigate whether IFN-g receptor signal–disrupted uNK
Figure 4. Histogram comparing mean ra-
tios of decidual vessel/lumen diameter in
unmanipulated and BM-engrafted RAG-
22/2gc
2/2 mice at gd 12. RAG-22/2gc
2/2
mice engrafted with BM from SCID, IFN-
gRa2/2, or Stat-12/2 mice or treated with
mrIFN-g (*) had lower vessel/lumen ratios
compared with those of unmanipulated
RAG-22/2gc
2/2 mice. There were signifi-
cant differences between RAG-22/2gc
2/2
mice engrafted with BM from IFN-g2/2
mice, unmanipulated or treated with PBS.
The mean decidual vessel/lumen diameter
ratio in normal C57BL/6 mice was 1.17 6
0.11. Values were obtained from 11 central
cross-sections per implantation site, 2–3 im-
plantation sites per dam. 4–5 dams were
used in each experimental group.264 Uterine Effects of IFN-g during Normal Pregnancy
cells, able to produce IFN-g but unable to respond to it,
could induce normal changes to decidual vessels and tissue,
RAG-22/2gc
2/2 females were infused with BM from IFN-
gRa2/2 or Stat-12/2 mice. Recipients had increased num-
bers of uNK cells and significantly larger MLAp compared
with B6 BM–engrafted controls (Figs. 1 and 2). The IFN-
gRa2/2 and Stat-12/2 BM–derived uNK cells had low
numbers of small cytoplasmic granules and appeared imma-
ture (Figs. 1 and 2). These transplants permitted normal,
pregnancy-induced remodeling of decidual arteries (Fig. 3)
and sustained highly cellular decidua (Fig. 5). Mean vessel/
lumen ratios from IFN-gRa2/2 or Stat-12/2 BM–engrafted
RAG-22/2gc
2/2 females were not significantly different
from those in control B6 BM–engrafted mice (Fig. 4).
Effects of Administration of mrIFN-g on RAG-22/2gc
2/2 Im-
plantation Sites. To determine if remodeling of decidual ar-
teries and normal cellularity of decidua in RAG-22/2gc
2/2
females reconstituted with IFN-g–competent uNK cells
could be fully attributed to IFN-g, pregnant RAG-22/2gc
2/2
mice were treated with mrIFN-g that was confirmed to be
bioactive (data not shown). In these mice, the decidual ar-
teries underwent pregnancy-induced remodeling, and the
decidua had normal cellularity after treatment with all dos-
ages examined (100–1,000 U/d for 6 d; Fig. 6). The arterial
vessel/lumen ratios in IFN-g–treated mice were similar to
those in B6 BM–engrafted controls but different from those
in pregnant RAG-22/2gc
2/2 mice treated with PBS or left
untreated (Fig. 4).
Assessment of Implantation Sites in RAG-22/2gc
2/2 Females
Infused with TNF-a2/2 or TNF-R12/2 BM Cells. TNF-a
is a pleiotropic, uNK cell–derived regulatory cytokine (26).
To assess whether cytokine-mediated effects of uNK cells
are restricted to IFN-g, RAG-22/2gc
2/2 females were en-
grafted with BM from TNF-a2/2 or TNF-R12/2 mice.
uNK cells and MLAp were present at the implantation sites
of reconstituted mice. Density (number of uNK cells per
square millimeter) and granularity of uNK cells (Fig. 7) and
the cross-sectional areas of MLAp were similar to those in
Figure 5. Comparison of decidual
morphology in unmanipulated and
BM-engrafted RAG-22/2gc
2/2 mice
at gd 12. A shows a very hypocellular
edematous decidua from an unmanip-
ulated RAG-22/2gc
2/2 mouse. C is
decidua from RAG-22/2gc
2/2 mice
engrafted with IFN-g2/2 BM. De-
cidua in these recipients was either
necrotic (C) or hypocellular (not
shown). B–F show normal decidual
morphology in RAG-22/2gc
2/2 mice
engrafted with B6, SCID, IFN-
gRa2/2, or Stat-12/2 BM cells, re-
spectively. Excessive numbers of uNK
cells (arrows) were present in the de-
cidua of RAG-22/2gc
2/2 recipients of
IFN-gRa2/2 or Stat-12/2 BM (E and
F) compared with control (B). A–F
were stained with PAS. Bars, 50 mm.265 Ashkar et al.
RAG-22/2gc
2/2 females engrafted with B6 BM. Decidua
in these recipients were normal histologically, and the de-
cidual arteries had undergone normal pregnancy-induced
modification (Fig. 7). The mean arterial vessel/lumen ratio
was 1.26 6 0.21, which is similar to the ratios in B6 BM–
engrafted RAG-22/2gc
2/2 controls and different from ra-
tios measured in pregnant, nonengrafted RAG-22/2gc
2/2
females. A summary of the results is shown in Table I.
Discussion
The goal of these experiments was to define the func-
tions of uNK cell–derived IFN-g during pregnancy. A new
animal model was developed based upon manipulation of
RAG-22/2gc
2/2 females, the first strain reported to be ab-
solutely devoid of uNK cells (15). It was first necessary to
define the amounts of IFN-g produced at RAG-22/2gc
2/2
implantation sites. Pregnancy induced mesometrial IFN-g
at low but constant concentrations, supporting previous
findings in tge26 mice, an immune-deficient strain having
1% of normal levels of uNK cells (9, 21). This suggests that
(a) the low constant production of IFN-g in tge26 is not
derived from uNK cells, (b) nonlymphoid cells are induced
by pregnancy to produce IFN-g within implantation sites,
and (c) uNK cells are the only cell population responsible
for the midgestation (gd 10) rise in mesometrial IFN-g
concentrations. Macrophages, neutrophils, and/or decidual
cells have been suggested as possible nonlymphoid sources
of IFN-g in the pregnant uterus (8, 27, 28).
Transplantation of IFN-g2/2 BM to RAG-22/2gc
2/2
mice generated implantation sites displaying only some of
the features seen in homozygously mated IFN-g2/2 mice.
Although uNK cells appeared typical and their total num-
bers were appropriately regulated, the decidua had the
properties of the donor strain, not the host strain. The ma-
jor difference between the host (RAG-22/2gc
2/2) and do-
nor strains is that the host mesometrial uterus produces low
amounts of IFN-g, whereas the donor strain does not. This
suggests that the terminal differentiation (not initial activa-
tion) and population size regulation of uNK cells is medi-
ated by low concentrations of IFN-g, which, however, are
insufficient to influence the vascular target cells. In normal
mice, small uNK cells with limited numbers of small gran-
ules are seen about gd 8, leading us to suggest that the ex-
cessively accumulated small, hypogranular cells reported
here are arrested in their maturation by a block in IFN-g
signaling. An alternate explanation is that they are gd-appro-
priate in maturity but alternatively differentiated. The
known roles of IFN-g in regulation of apoptosis, via IFN
regulatory factor 1 and bcl2 (2), are consistent with the ob-
servation of excessive uNK cell numbers at gd 10–14 in
IFN-g2/2 mice but not in RAG-22/2gc
2/2 females trans-
planted with IFN-g2/2 BM. In normal mice, the regula-
tion of uNK cell granularity frequency is probably auto-
crine, because normal uNK cells produce more IFN-g than
the nonlymphoid cells in the uterus. Engraftment of RAG-
22/2gc
2/2 mice with normal B6 or with SCID
(T2B2NK1) BM restored normal uNK cells, resulting in
full correction of the pathology seen in nonmanipulated
RAG-22/2gc
2/2 females. This confirmed the central role
of uNK cells in these changes but did not define the mech-
anisms involved.
Figure 6. Comparison of decidua
and decidual artery morphology in
pregnant RAG-22/2gc
2/2 mice
treated with placebo (PBS) or
mrIFN-g (1,000 U/d) for 6 d. A and
C are cross-sections of unmodified
spiral arteries and hypocellular de-
cidua, respectively, from PBS-
treated females. B is a cross-section
of modified decidual artery from
IFN-g–treated females. D shows
normal decidual morphology in
IFN-g–treated mice. A–D were
stained with PAS. Bars, 50 mm.266 Uterine Effects of IFN-g during Normal Pregnancy
Figure 7. Photomicrographs of
implantation site morphology from
RAG-22/2gc
2/2 mice engrafted with
TNF-a2/2 BM (A, C, and E) or
TNF-R12/2 BM (B, D, and F). uNK
cells were established with normal
mature morphology and cell density
(A and B) compared with B6 BM–
engrafted control. Decidual arteries
underwent normal pregnancy-induced
remodeling (C and D, compared with
Fig. 3 B). Decidua had normal mor-
phology (E and F, compared with Fig.
5 B). Arrows point to uNK cells. A–F
were stained with PAS. Bars, 50 mm.
Table I.  Summary of Results
Experimental group
 uNK cell 
frequency
uNK cell 
granularity
MLAp
size
Decidual
morphology
Arterial
remodeling
Nonengrafted RAG-22/2gc
2/2 – – –  hypocellular –
B6 (control) N N N N N
RAG-22/2gc
2/2 + IFN-g2/2 BM  N N N necrotic –
RAG-22/2gc
2/2 + IFN-gRa2/2 BM increased  decreased increased  N N
RAG-22/2gc
2/2 + Stat-12/2 BM  increased  decreased increased  N N
RAG-22/2gc
2/2 + TNF-a2/2 BM N N N N N
RAG-22/2gc
2/2 + TNF-R12/2 BM N N N N N
RAG-22/2gc
2/2 + mrIFN-g –––N N
RAG-22/2gc
2/2 + PBS – – –  hypocellular –
N, normal.267 Ashkar et al.
RAG-22/2gc
2/2 recipients of IFN-gRa2/2 or Stat-12/2
BM demonstrated implantation sites that shared only part of
the phenotype seen in homozygously mated IFN-gRa2/2
(9) or Stat-12/2 mice (our unpublished data). This pheno-
type was distinct from but complementary to that seen in
RAG-22/2gc
2/2 mice engrafted with IFN-g2/2 BM. In
recipients of IFN-gRa2/2 or Stat-12/2 BM, the decidual
arteries became modified in a normal manner, as assessed by
morphology and morphometric measurements. The estab-
lished uNK cell population, however, was excessive in
number and comprised of small, relatively hypogranular
cells. These uNK cells are unimpaired in IFN-g produc-
tion; NK cells from IFN-gRa2/2 mice produce IFN-g in
amounts similar to those of their congenic partners (29, 30).
The correction of both decidua and decidual BV anomalies
in RAG-22/2gc
2/2 females engrafted with BM from IFN-
gRa2/2 or Stat-12/2 mice indicates that uNK cell–derived
IFN-g is the initiator of these changes. Furthermore, IFN-
g–mediated gene regulation in uterine arteries and decidua
appears to require higher concentrations of cytokine than
the IFN-g–mediated gene regulation in uNK cells. The
immaturity and overgrowth of uNK cells is explained by
their inability to respond to IFN-g due to dysfunction in
the signaling pathway involving receptor engagement or
Stat-1 activation. This indicates that regulation of uNK cell
maturation is by Stat-1–regulated genes.
The results obtained in mrIFN-g–treated pregnant
RAG-22/2gc
2/2 mice confirm that IFN-g alone, indepen-
dent of the presence of uNK cells, is sufficient to initiate
pregnancy-induced remodeling of decidual arteries and to
support integrity of decidua. IFN-g, in the doses em-
ployed, has been reported by others to be highly abortifa-
cient in mice, even with a single treatment (31, 32). One
explanation for the survival of fetuses in IFN-g–treated
alymphoid RAG-22/2gc
2/2 females is that exogenous
IFN-g activates lymphocytes in normal mice that mediate
abortion. However, daily treatment of fully immune com-
petent B6 mice (n 5 4) with 1,000 U of mrIFN-g for 6 d
in the same experiment did not elevate the resorption rates
over PBS-treated B6 controls (data not shown). Thus,
there appear to be genetic differences in susceptibility to
IFN-g–mediated abortion (33). In previous studies, high
dose TNF-a given in combination with IFN-g induced
abortion in B6 mice (34). TNF-a is present in RAG-22/2
gc
2/2 mice, suggesting that normal levels of TNF-a com-
bined with high doses of IFN-g are compatible with
healthy pregnancy. Using transfer of TNF-a2/2 BM, we
were unable to establish a role for TNF-a in initiating the
normal pregnancy-induced remodeling of decidual arteries,
maintenance of decidual integrity, or uNK cell maturation/
senescence.
Pregnancy is associated with extensive uterine remodel-
ling, cell proliferation, and cell invasion. For both uNK
cells and decidua, it has been postulated that their major
functions are to limit trophoblast invasion (35). This study
discounts that idea, as placental size in all experiments
matches that in B6 BM–engrafted RAG-22/2gc
2/2 mice
and in B6 nonmanipulated pregnancy (data not shown).
uNK cell–derived IFN-g is not necessary for initiation of
decidualization (9) or for its development to gd 6 but seems
to be essential for decidual maintenance in the second tri-
mester, gd 7–14 (9, 15). It is most surprising that collapse of
decidua at midgestation does not lead to pregnancy disrup-
tion, whereas failure of decidualization in early gestation
results in pregnancy termination (36). It has been docu-
mented ultrastructurally that some human uNK cells can
form gap junctions with decidual cells and that this pro-
motes survival of both cell types (10). Such data indicate
that uNK cells may differ from other NK cell subsets by
preferentially using decidua as their supporting stroma. The
process of trophoblast invasion into the decidualized tissue
is mediated by the balance between extracellular pro-
teolytic enzymes and their inhibitor systems, including a2-
macroglobulin, a known product of mesometrial decidua
that is regulated by IFN-g (2, 37, 38). Dysregulation of
these systems in the absence of IFN-g may promote pro-
teolysis of decidua and its matrix. In RAG-22/2gc
2/2
mice, low amounts of uIFN-g may be weakly protective
from proteolytic enzymes, providing a hypocellular pheno-
type. In IFN-g2/2, IFN-gRa2/2, or Stat-12/2 mice, pro-
teolytic action may destroy late decidua gaining necrotic
phenotype.
The mechanisms initiating mammalian pregnancy-induced
uterine artery remodeling are not known. Adult BV,
other than those of the uterus and ovary, are stable (39).
Angiopoietin-1 is involved in BV stabilization when ligated
to its receptor, Tie-2 (40). Ablation of murine Tie-2 dis-
rupts vessel structure (41). In this study, relatively high
concentrations of IFN-g were required for initiation of
uBV remodeling during pregnancy. uNK cells are highly
migratory cells, and at gd 10, in mesometrial decidua of
normal B6 pregnancy, 5% of uNK cells are in the arteries/
arterioles and 25% are associated with the muscular walls of
these vessels (our unpublished data and Fig. 3). It is likely
that short range, high concentration uNK cell–derived
IFN-g signaling initiates destabilization of the decidual ar-
teries, permitting vessel wall thinning and lumen increase
by two complementary mechanisms. The first is indirect
IFN-g–regulated changes to gene expression in target tis-
sues (smooth muscle, endothelial cells, and matrix) (18).
The second is direct actions on BV. Human uNK cells ex-
press angiopoietin-2 (42), a natural competitive antagonist
to the Tie-2 receptor of endothelium (40, 43), and they
express NK5 (44), an angiogenic factor. Thus, in addition
to initiating uterine arterial instability, uNK cells may play
later roles in branching angiogenesis within implantation
sites. Actions of host NK cells on allografted vessels are re-
ported as destructive (45, 46). Future studies will be needed
to clarify whether unusual aspects of fetal antigen presenta-
tion, uterine endothelial cell activation, decidual matrix
composition, or the subsets of NK cells involved account
for our novel finding that IFN-g from uNK cells is central
in initiation of uterine arterial remodeling.
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